Ventyx Biosciences Inc

Stock Chart, Company Information, and Scan Results

$13.96(as of Feb 13, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ventyx Biosciences Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$13.96
Ticker SymbolVTYX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees83
CountyUSA
Market Cap$1,000.2M
EBIDTA-116.4M
10-Day Moving Average13.95
P/E Ratio-9.32
20-Day Moving Average13.94
Forward P/E Ratio0.00
50-Day Moving Average11.35
Earnings per Share-1.49
200-Day Moving Average5.58
Profit Margin-Infinity%
RSI72.16
Shares Outstanding71.8M
ATR0.37
52-Week High15.34
Volume6,481,638
52-Week Low0.78
Most Recent Support Level13.89
Book Value191.4M
Most Recent Resistance Level13.97
P/B Ratio5.19
Upper Keltner14.77
P/S Ratio685.96
Lower Keltner13.11
Debt-to-Equity Ratio14.77
Next Earnings Date03/19/2026
Cash Surplus20.7M
Next Ex-Dividend DateUnknown

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn's disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor that is in Phase 2a trial for patients with early Parkinson's disease and is in Phase 2 trial for patients with obesity and additional risk factors for cardiovascular disease. Ventyx Biosciences, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Ventyx Biosciences Inc In Our Stock Scanner

As of Feb 13, 2026
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Channel Pattern RangeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.